Zenopa Positive topline results from the eight-week pivotal phase III trial showed that the investigational fixed-dose combination (FDC) of nebivolol and valsartan can potentially provide a number of benefits. It delivered statistically significant reductions ... and more »
FiercePharma India's Business Standard, citing sources, says that Ranbaxy received a Form 483 from the FDA several months ago following an inspection of supplies of val...
Wall Street Journal The nebivolol/ valsartan combination is among the product candidates in Forest Labs' late-stage development pipeline. Like other pharmaceutical companies, Forest Lab has been looking for new products to help offset the loss of former blockbuster drugs ...
MarketWatch (press release) 2. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive subjects at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-2031. 3. Sever PS, Dahlof B, Poulter NR et al. and more »
MedPage Today With a primary endpoint of change from baseline in sitting trough diastolic pressure, several fixed-dose combinations of nebivolol and valsartan produced reductions of 1.2 to 2.4 mm Hg against nebivolol alone at the same doses, and 3.7 to 4.4 mm Hg ... and more »
Reuters UK June 27 (Reuters) - Forest Laboratories Inc said on Thursday that combining Bystolic, the brand name for nebivolol, and valsartan to treat hypertension in a clinical trial was more effective at lowering blood pressure than either nebivolol or valsartan ...
pharmabiz.com The combination of nebivolol and valsartan demonstrated statistically significant reductions in diastolic blood pressure (DBP) vs. both nebivolol alone and valsartan alone at eight weeks, which was the primary endpoint. The FDC also met the key ...
Medisite Le valsartan peut être utilisé avec d'autres traitements du post-infarctus du myocarde, par exemple les agents thrombolytiques, l'acide acétylsalicylique, les bêtabloquants, les statines et les diurétiques. L'association avec les inhibiteurs de l ...
